MIKSAFE 250 TABLET

Product Description

MIKSAFE 250 TABLET Cefuroxime Axetil IP 250 mg | Broad-Spectrum Antibiotic for Trusted Infection Control

MIKSAFE 250 TABLET is a high-quality pharmaceutical formulation containing Cefuroxime Axetil IP 250 mg, a second-generation cephalosporin antibiotic known for its broad-spectrum efficacy against a wide range of gram-positive and gram-negative bacterial infections. Manufactured under stringent GMP standards, MIKSAFE 250 ensures consistent performance and patient safety.

Key Features:

• Active Ingredient: Cefuroxime Axetil IP 250 mg

• Form: Oral Tablet | Unit Pack: Blister Strip

• Pharmacological Class: Cephalosporin Antibiotic

• Shelf Life: 2436 months

• Certification: GMP-compliant | ISO certified manufacturer

Benefits:

• Effective treatment for respiratory tract infections, urinary tract infections (UTIs), skin & soft tissue infections, and ENT infections

• Acid-stable formulation ensures optimal absorption and bioavailability

• Well-tolerated across adult and pediatric age groups (as per medical advice)

• Ideal for hospitals, clinics, pharmacies, and pharmaceutical distributors

Usage/Application:

MIKSAFE 250 is prescribed to manage bacterial infections caused by susceptible organisms. Dosage should be directed by a registered medical practitioner.

Ideal For:

• Medical wholesalers and distributors

• Hospital procurement departments

• Pharmacy retail chains

• Bulk purchase and PCD pharma franchise inquiries